-
Trospium chloride is a
muscarinic antagonist used to
treat overactive bladder. It has side
effects typical of this
class of drugs,
namely dry mouth, stomach...
- Xanomeline/
trospium chloride, sold
under the
brand name Cobenfy, is a fixed-dose
combination medication used for the
treatment of schizophrenia. It contains...
- Xanomeline/
trospium, sold
under the
brand name Cobenfy, is an
approved combination drug used in the
treatment of schizophrenia.
Trospium chloride is...
- D2/3
partial agonist. Xanomeline/
trospium chloride (Cobenfy) - A fixed-dose
combination of
xanomeline and
trospium chloride.
Xanomeline is a functionally...
- Xanomeline, the anti-schizophrenia
component in the
approved drug xanomeline/
trospium chloride, has
structural similarities to arecoline.
Nipecotic acid Nicotinic...
- has been
proposed as a
potential treatment for schizophrenia. Xanomeline/
trospium chloride was
approved in the US in 2024.
Based on
preclinical pharmacological...
-
preferentially acting M1/M4
muscarinic acetylcholine receptor agonist) with
trospium (a peripherally-restricted pan-mAChR
antagonist for use in schizophrenia...
- in post-marketing
reports about topiramate;
antimuscarinic drugs (like
trospium) can
aggravate these disorders.[citation needed] The
topiramate molecule...
-
Trimebutine Tripitamine (tripitramine)
Tropacine Tropatepine Tropicamide Trospium chloride Typical antipsychotics (e.g., chlorpromazine, chlorprothixene...
-
adherence to treatment. The fixed-dose
combination medication xanomeline/
trospium chloride (Cobenfy) was
approved for
medical use in the
United States in...
